ClinicalTrials.gg
Drug

Cariprazine clinical trials

Also written Vraylar, RGH-188 and MP-214.

studies test it
53
open now
8
in phase 3
27
first study started
2006

How each study uses cariprazine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the cariprazine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
17 Sept 2015 · VRAYLAR · NDA 204370 (FDA, Drugs@FDA)
European Union
13 Jul 2017 · Reagila · EMEA/H/C/002770 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Cariprazine
35
MP-214 3mg
3
MP-214 6mg
3
MP-214 9mg
3

Brand

Vraylar
11
Vraylar® 1.5 mg
1
Vraylar® 3.0 mg
1
Vraylar® 4.5 mg
1
Vraylar® 6.0 mg
1

Development codes

RGH-188
9
MP-214
2
AGN-241780
1

Studies by the year they started

53 studies that test it; most in 2010 (6)

Studies that test cariprazine, by start year
YearStudies
20061
20071
20082
20093
20106
20114
20126
20131
20141
20162
20185
20191
20201
20215
20225
20243
20251
20265

By phase

A phase 1/2 study counts in both.

Phase 1
7
Phase 2
19
Phase 3
27
Phase 4
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 41 · Other 12

Forest Laboratories (20) · AbbVie (9) · Tanabe Pharma Corporation (6) · Gedeon Richter Plc. (2) · New York State Psychiatric Institute (2) · Massachusetts General Hospital (1) · Humanis Saglık Anonim Sirketi (1) · Kyle Kampman (1)

Often tested with

Tested in the same studies.

Aripiprazole (1) · Escitalopram (1) · Quetiapine (1) · Lurasidone (1) · Antidepressive Agents (1) · Brexpiprazole (1) · Lithium (1) · Vortioxetine (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4, 3 in phase 3

Studies that test cariprazine, phase 3 first.

Studies

Open first, then newest update. How each study uses cariprazine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 53

See all 53 studies that test cariprazine →

As the comparator · 2 — what is tested is compared with cariprazine

Codes

What other systems call cariprazine · ClinicalTrials.gg INT005356

  • MeSH (NLM) C533287cariprazineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) F6RJL8B278CARIPRAZINEConfirmed FDA, NLM, Wikidata
  • RxNorm 1667655Confirmed FDA, Wikidata
  • Wikidata Q2938837cariprazineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C169826CariprazineOne source FDA
  • DrugBank DB06016One source Wikidata

Also registered as cariprazine hydrochloride (UNII KQD7C255YG · RxNorm 1721073).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.